Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CG2001 in Chinese adult males with androgenetic alopecia
NCT07076706Phase 2Completed
- Sponsor
- Beijing Dayspring Pharmaceutical Technology
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CG2001 in androgenetic alopecia (AGA), sponsored by Beijing Dayspring Pharmaceutical Technology. Started Dec 2024; status: completed.
02
Drugs
CG2001
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07076706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076706.